TANDEM DIABETES CARE INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tandem Diabetes Care Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Tandem Diabetes Care Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $87.4M, a 2.28% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $87.4M -$2.04M -2.28% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $88.2M -$2.81M -3.09% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $88.3M -$16.5M -15.7% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $87.8M -$22.8M -20.6% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $89.4M -$27M -23.2% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $91.1M -$35.6M -28.1% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $105M -$26.3M -20.1% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $111M +$83.1M +302% Dec 31, 2022 10-K 2024-02-21
Q3 2022 $116M +$86.8M +292% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $127M +$95.2M +302% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $131M +$97.8M +294% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $27.5M +$7.73M +39.1% Dec 31, 2021 10-K 2023-02-22
Q3 2021 $29.7M +$8.36M +39.2% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $31.5M +$9.95M +46.1% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $33.3M +$10.3M +44.6% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $19.8M +$4.21M +27.1% Dec 31, 2020 10-K 2022-02-22
Q3 2020 $21.3M +$4.75M +28.6% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $21.6M +$3.89M +22% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $23M +$12.9M +128% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $15.6M Dec 31, 2019 10-K 2021-02-24
Q3 2019 $16.6M Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $17.7M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $10.1M Mar 31, 2019 10-Q 2019-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.